474 results on '"Loiseau, Philippe M."'
Search Results
2. Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
3. Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis
4. Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
5. 1,2,3-triazenes and 1,2,3-triazoles as antileishmanial, antitrypanosomal, and antiplasmodial agents
6. Pharmacokinetics, biodistribution, and activity of Amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model
7. The Synthesis of 2′-Hydroxychalcones under Ball Mill Conditions and Their Biological Activities
8. In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
9. In vitro antileishmanial potentialities of essential oils from Citrus limon and Pistacia lentiscus harvested in Tunisia
10. Combination of amphotericin B and chitosan platelets for the treatment of experimental cutaneous leishmaniasis: Histological and immunohistochemical examinations
11. Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4 H -tetrahydro-thiopyran-4-one S -Oxides: Their Interplay in a Cascade of Redox Reactions from Diarylideneacetones.
12. Synthesis and antikinetoplastid evaluation of bis(benzyl)spermidine derivatives
13. In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B
14. Polyamine-based analogs and conjugates as antikinetoplastid agents
15. Anti-fungal and anti-leishmanial activities of pectin-amphotericin B conjugates
16. Synthesis and in vitro antikinetoplastid activity of polyamine–hydroxybenzotriazole conjugates
17. Nanoassemblies from amphiphilic Sb complexes target infection sites in models of visceral and cutaneous leishmaniases
18. New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani
19. Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors
20. Comparative study of structural models of Leishmania donovani and human GDP-mannose pyrophosphorylases
21. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis
22. In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route
23. Gelation and micellization behaviors of pluronic® F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application
24. Targeting sterol metabolism for the development of antileishmanials
25. 1,2,3-triazenes and 1,2,3-triazoles as antileishmanial, antitrypanosomal, and antiplasmodial agents
26. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model
27. Drug Targets, Drug Effectors, and Drug Targeting and Delivery
28. Stimulation of Acanthamoeba castellanii excystment by enzyme treatment and consequences on trophozoite growth
29. Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
30. Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases
31. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations
32. Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana
33. Simple and efficient synthesis of 5 ′ -deoxyguanosine analogs by azide-alkyne click reaction and their antileishmanial activities
34. Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
35. Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe
36. Clotrimazole-loaded nanostructured lipid carrier hydrogels: Thermal analysis and in vitro studies
37. Synthesis of novel guttiferone A derivatives: In-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani
38. Cyclodextrin-mediated self-associating chitosan micro-platelets act as a drug booster against Candida glabrata mucosal infection in immunocompetent mice
39. In situ forming pluronic® F127/chitosan hydrogel limits metronidazole transmucosal absorption
40. Drug-Free Chitosan Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active Against Trichomonas vaginalis and Non-Toxic Towards Pig Vaginal Mucosa
41. Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for a lipidomic analysis of Leishmania donovani
42. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives
43. The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
44. Membrane lipidomics for the discovery of new antiparasitic drug targets
45. Minor Impact of A258D Mutation on Biochemical and Enzymatic Properties of Leishmania infantum GDP-Mannose Pyrophosphorylase
46. Leishmania hijacking of the macrophage intracellular compartments
47. Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes
48. Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis
49. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells
50. Perspectives for parasitology and parasitology networks in Europe
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.